SLShuyu Lin

Shuyu Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shuyu Lin has a total of 143 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Resilient nanostructured bioanalytic microneedle longitudinally monitors preclinical renal and hepatic drug clearance and dysfunction

    by Jialun Zhu, Xuanbing Cheng, Mohammadreza Bahramian, Kuanming Yao, Zongqi Li, Bintao Hu, Tsung-Yu Wu, Kiarash A. Sabet, Jiarui Cui, Jiawei Tan, et al.

    Wearable microneedle biosensors promise real-time molecular monitoring for precision medicine but are limited by low sensitivity and tissue abrasion. Overcoming these challenges, we recast electrode functionality not merely as a sensing substrate but as a mechanism for resilient, high signal-to-noise ratio (SNR) measurements in tissue. Our microneedle-based resilient nanostructured bioelectrode (RNB) is fabricated using a bilayer process that strengthens the electrode with a micrometer-thick gold adhesion layer and reduces fabrication-induced stress through controlled dealloying. The resulting RNBs are corrosion resistant, stable over a wide potential window, and have an artifact-free, nanocavity-textured interface. They integrate receptor-based electrochemical biosensors with enhanced SNR through increased active area, diffusion, and antifouling while remaining abrasion immune in megapascal-stiff tissues. The RNB extended in vivo biosensor lifetime for pharmacokinetics monitoring to 6 days in a freely moving rat. Paired with a blood–interstitial fluid equilibrium–based bioanalytical framework, the RNB accurately derived blood-equivalent pharmacokinetic parameters, enabling not only precision dosing of narrow therapeutic index drugs but also the direct assessment of hepatic and renal clearance. In hepatic studies, the RNB revealed delayed clearance of a chemotherapeutic (irinotecan) in liver-damaged models. In renal studies, RNB recordings correlated with blood antibiotic pharmacokinetics across chronic kidney disease severities. The RNB detected renal impairment earlier than conventional biomarker thresholds through drug clearance quantification and captured recovery under therapeutic intervention. These results establish the RNB as a viable microneedle platform for high-fidelity in vivo deployment of electrochemical biosensors, enabling minimally invasive, longitudinal monitoring of low-concentration analytes and real-time assessment of organ function.


  • Open Access

    Tandem metabolic reaction–based sensors unlock in vivo metabolomics

    by Xuanbing Cheng, Zongqi Li, Jialun Zhu, Jingyu Wang, Ruyi Huang, Lewis W. Yu, Shuyu Lin, Sarah Forman, Evelina Gromilina, Sameera Puri, et al.

    Mimicking metabolic pathways on electrodes enables in vivo metabolite monitoring for decoding metabolism. Conventional in vivo sensors cannot accommodate underlying complex reactions involving multiple enzymes and cofactors, addressing only a fraction of enzymatic reactions for few metabolites. We devised a single-wall-carbon-nanotube-electrode architecture supporting tandem metabolic pathway–like reactions linkable to oxidoreductase-based electrochemical analysis, making a vast majority of metabolites detectable in vivo. This architecture robustly integrates cofactors, self-mediates reactions at maximum enzyme capacity, and facilitates metabolite intermediation/detection and interference inactivation through multifunctional enzymatic use. Accordingly, we developed sensors targeting 12 metabolites, with 100-fold-enhanced signal-to-noise ratio and days-long stability. Leveraging these sensors, we monitored trace endogenous metabolites in sweat/saliva for noninvasive health monitoring, and a bacterial metabolite in the brain, marking a key milestone for unraveling gut microbiota–brain axis dynamics.


  • Non‐Invasive Touch‐Based Lithium Monitoring Using an Organohydrogel‐Based Sensing Interface

    by Shuyu Lin, Jialun Zhu, Justin Yeung, Tsung‐Yu Wu, Xuanbing Cheng, Yichao Zhao, Bo Wang, Jiawei Tan, Sophie Peeters, Ariel Seroussi, et al.

    Lithium is a drug widely employed for the treatment of bipolar disorder owing to its high efficacy in mood management and suicide prevention. However, this efficacy is often undermined by misdosing and nonadherence, and diligent drug monitoring is required during treatment. Standard lithium monitoring involves invasive blood collections and laboratory analysis with low time granularity. Recent advances in sensor technology have enabled the development of personalized drug‐monitoring devices that analyze biomarker information noninvasively. Herein, based on the fact that the analyte partition onto the fingertip with a high flux, a touch‐based noninvasive monitoring modality for managing lithium pharmacotherapy is devised. The system is built based on a thin organohydrogel‐mounted lithium ion‐selective electrode (TOH‐ISE). The TOH coating provides a stable environment for sensing. Through the utilization of a water/glycerol bi‐solvent matrix, the gel exhibits dehydration‐resist properties, rendering a controlled micro‐environment for ISE conditioning, and subsequently minimizing signal drift. To illustrate the clinical application of the solution, the system is tested on a subject prescribed lithium. The system successfully detected the increase in circulating drug levels following medication intake. Collectively, the results indicate the devised solution is capable to facilitate lithium adherence monitoring and has broader potential for optimizing lithium pharmacotherapy.


  • Open Access

    Data from EGFR Promotes Lung Tumorigenesis by Activating miR-7 through a Ras/ERK/Myc Pathway That Targets the Ets2 Transcriptional Repressor ERF

    by Yu-Ting Chou, Hua-Heng Lin, Yung-Chang Lien, Yuan-Hung Wang, Chun-Fu Hong, Yu-Rung Kao, Sheng-Chieh Lin, Ying-Che Chang, Shu-Yu Lin, Shu-Jen Chen, et al.

    MicroRNAs (miRNA) mediate distinct gene regulatory pathways triggered by epidermal growth factor receptor (EGFR) activation, which occurs commonly in lung cancers with poor prognosis. In this study, we report the discovery and mechanistic characterization of the miRNA miR-7 as an oncogenic “oncomiR” and its role as a key mediator of EGFR signaling in lung cancer cells. EGFR activation or ectopic expression of Ras as well as c-Myc stimulated miR-7 expression in an extracellular signal-regulated kinase (ERK)–dependent manner, suggesting that EGFR induces miR-7 expression through a Ras/ERK/Myc pathway. In support of this likelihood, c-Myc bound to the miR-7 promoter and enhanced its activity. Ectopic miR-7 promoted cell growth and tumor formation in lung cancer cells, significantly increasing the mortality of nude mice hosts, which were orthotopically implanted with lung cancers. Quantitative proteomic analysis revealed that miR-7 decreased levels of the Ets2 transcriptional repression factor ERF, the coding sequence of which was found to contain a miR-7 complementary sequence. Indeed, ectopic miR-7 inhibited production of ERF messages with a wild-type but not a silently mutated coding sequence, and ectopic miR-7 rescued growth arrest produced by wild-type but not mutated ERF. Together, these results identified that ERF is a direct target of miR-7 in lung cancer. Our findings suggest that miR-7 may act as an important modulator of EGFR-mediated oncogenesis, with potential applications as a novel prognostic biomarker and therapeutic target in lung cancer. Cancer Res; 70(21); 8822–31. ©2010 AACR.

  • Top Cited Papers

    Soft strain-insensitive bioelectronics featuring brittle materials

    by Yichao Zhao, Bo Wang, Jiawei Tan, Hexing Yin, Ruyi Huang, Jialun Zhu, Shuyu Lin, Yan Zhou, David Jelinek, Zhengyang Sun, et al.

    Advancing electronics to interact with tissue necessitates meeting material constraints in electrochemical, electrical, and mechanical domains simultaneously. Clinical bioelectrodes with established electrochemical functionalities are rigid and mechanically mismatched with tissue. Whereas conductive materials with tissue-like softness and stretchability are demonstrated, when applied to electrochemically probe tissue, their performance is distorted by strain and corrosion. We devise a layered architectural composite design that couples strain-induced cracked films with a strain-isolated out-of-plane conductive pathway and in-plane nanowire networks to eliminate strain effects on device electrochemical performance. Accordingly, we developed a library of stretchable, highly conductive, and strain-insensitive bioelectrodes featuring clinically established brittle interfacial materials (iridium-oxide, gold, platinum, and carbon). We paired these bioelectrodes with different electrochemical probing methods (amperometry, voltammetry, and potentiometry) and demonstrated strain-insensitive sensing of multiple biomarkers and in vivo neuromodulation.


  • Top Cited Papers
    Open Access

    Wearable microneedle-based electrochemical aptamer biosensing for precision dosing of drugs with narrow therapeutic windows

    by Shuyu Lin, Xuanbing Cheng, Jialun Zhu, Bo Wang, David Jelinek, Yichao Zhao, Tsung-Yu Wu, Abraham Horrillo, Jiawei Tan, Justin Yeung, et al.

    Therapeutic drug monitoring is essential for dosing pharmaceuticals with narrow therapeutic windows. Nevertheless, standard methods are imprecise and involve invasive/resource-intensive procedures with long turnaround times. Overcoming these limitations, we present a microneedle-based electrochemical aptamer biosensing patch (μNEAB-patch) that minimally invasively probes the interstitial fluid (ISF) and renders correlated, continuous, and real-time measurements of the circulating drugs’ pharmacokinetics. The μNEAB-patch is created following an introduced low-cost fabrication scheme, which transforms a shortened clinical-grade needle into a high-quality gold nanoparticle-based substrate for robust aptamer immobilization and efficient electrochemical signal retrieval. This enables the reliable in vivo detection of a wide library of ISF analytes—especially those with nonexistent natural recognition elements. Accordingly, we developed μNEABs targeting various drugs, including antibiotics with narrow therapeutic windows (tobramycin and vancomycin). Through in vivo animal studies, we demonstrated the strong correlation between the ISF/circulating drug levels and the device’s potential clinical use for timely prediction of total drug exposure.


  • Open Access

    A touch-based multimodal and cryptographic bio-human–machine interface

    by Shuyu Lin, Jialun Zhu, Wenzhuo Yu, Bo Wang, Kiarash A. Sabet, Yichao Zhao, Xuanbing Cheng, Hannaneh Hojaiji, Haisong Lin, Jiawei Tan, et al.

    Significance: The awareness of the individuals’ biological status is critical for creating interactive environments. Accordingly, we devised a multimodal cryptographic bio-human–machine interface (CB-HMI), which seamlessly translates touch-based entries into encrypted biochemical, biophysical, and biometric indices (i.e., circulating biomarkers levels, heart rate, oxygen saturation level, and fingerprint pattern). As its central component, the CB-HMI features thin hydrogel-coated chemical sensors and a signal interpretation framework to access/interpret biochemical indices, bypassing the challenge of circulating analyte accessibility and the confounding effect of pressing force variability. Upgrading the surrounding objects with CB-HMI, we demonstrated new interactive solutions for driving safety and medication use, where the integrated CB-HMI uniquely enabled one-touch bioauthentication (based on the user’s biological state/identity), prior to rendering the intended services.


  • Top Cited Papers
    Open Access

    Wearable aptamer-field-effect transistor sensing system for noninvasive cortisol monitoring

    by Bo Wang, Chuanzhen Zhao, Zhaoqing Wang, Kyung-Ae Yang, Xuanbing Cheng, Wenfei Liu, Wenzhuo Yu, Shuyu Lin, Yichao Zhao, Kevin M. Cheung, et al.

    A smartwatch was developed for noninvasive stress biomarker data acquisition that provides real-time feedback to the wearer.


  • An Adhesive and Corrosion-Resistant Biomarker Sensing Film for Biosmart Wearable Consumer Electronics

    by Yichao Zhao, Bo Wang, Hannaneh Hojaiji, Shuyu Lin, Haisong Lin, Jialun Zhu, Christopher Yeung, Sam Emaminejad

    The integration of electrochemical sensors in wearable consumer electronics enables monitoring the health status of individuals at molecular levels across the general population, and thus can play a critical role in transforming personalized and precision medicine. Previously, we devised a seamless integration strategy to interface disposable mediator-free enzymatic sensors--constructed on anisotropic conductive films (ACFs)--with consumer electronics. To illustrate the generalizability of our approach, here, we leverage ACF electrodes as a foundation to develop widely used mediator-based enzymatic sensors, which possess different underlying reaction mechanisms. Accordingly, we demonstrated the ACF-based sensor's anti-corrosive performance and its compatibility for integration with contact pads on both flexible and rigid substrates. To position this mediator-based sensor for untreated biofluid analysis, we adopted a post-calibration methodology to facilitate sensor surface conditioning. To demonstrate the clinical utility of our approach, a representative mediator-based enzymatic glucose sensor was developed and coupled with contact pads on a circuit board to analyze the changes in sweat glucose levels with respect to meal intake (n = 26). The generalizability of the ACF-based sensor development and integration strategy allows for its adoption to target a wide panel of biomarkers and to transform the wearable consumer electronics into biosmart platforms. [2020-0193]


  • An Autonomous Diurnal Sweat Sampling Patch for Biomarker Data Analytics

    by Hannaneh Hojaiji, Yichao Zhao, Shuyu Lin, Max C. Gong, Mudith Mallajosyula, Haisong Lin, Amir M. Hojaiji, Asad M. Madni, Sam Emaminejad

    Wearable sweat analysis possesses significant potential for transforming personalized and precision medicine, by capturing the longitudinal profiles of a broad spectrum of biomarker molecules that are informative of our body's dynamic chemistry. However, the lack of established physiological criteria to provide personalized feedback, based on sweat biomarker readings, has prevented the translation of wearable sweat-based bioanalytical technologies into health and wellness monitoring applications. Accordingly, scalable sweat sampling tools are required to facilitate large-scale and longitudinal clinical studies focusing on interpreting sweat biomarker readings. However, conventional sweat induction-collection tools are bulky and require multi-step and manual operations. Accordingly, here, we devise a sweat sampling patch, which can be deployed for autonomous diurnal sweat induction-collection. The core of this patch is an addressable array of miniaturized and coupled iontophoresis/microfluidic interfaces that can be activated on-demand or at scheduled time-points to induce/collect sufficient sweat samples for analysis. The iontophoresis interface was designed following an introduced design space centering on sufficient sweat secretory agonist delivery at safe current levels. The microfluidic interface was fabricated following a simple, rapid, and low-cost fabrication scheme. To achieve autonomous operation, these interfaces were extended into an array format and coupled with a custom-developed flexible and wireless circuit board. To inform utility, periodically induced/collected sweat samples of an individual were analyzed in relation to meal intake. [2020-0194]